메뉴 건너뛰기




Volumn 10, Issue 12, 2017, Pages 1189-1198

Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation

(137)  Nakamura, Masato a   Iijima, Raisuke a   Ako, Junya b   Shinke, Toshiro c,s   Okada, Hisayuki d,s   Ito, Yoshiaki e,s   Ando, Kenji f,s   Anzai, Hitoshi g,s   Tanaka, Hiroyuki h,s   Ueda, Yasunori i,s   Takiuchi, Shin j,s   Nishida, Yasunori k,s   Ohira, Hiroshi l,s   Kawaguchi, Katsuhiro m,s   Kadotani, Makoto n,s   Niinuma, Hiroyuki o,s   Omiya, Kazuto p,s   Morita, Takashi q,s   Zen, Kan r,s   Yasaka, Yoshinori s   more..


Author keywords

biodegradable polymer; drug eluting stent(s); dual antiplatelet therapy; net adverse clinical and cerebrovascular event(s); stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; POLYMER; TICLOPIDINE; ANTITHROMBOCYTIC AGENT;

EID: 85020865128     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2017.04.019     Document Type: Article
Times cited : (98)

References (25)
  • 1
    • 17844373254 scopus 로고    scopus 로고
    • Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
    • Iakovou, I., Schmidt, T., Bonizzoni, E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005), 2126–2130.
    • (2005) JAMA , vol.293 , pp. 2126-2130
    • Iakovou, I.1    Schmidt, T.2    Bonizzoni, E.3
  • 3
    • 84874216783 scopus 로고    scopus 로고
    • Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry
    • Kimura, T., Morimoto, T., Nakagawa, Y., et al. Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry. Cardiovasc Interv Ther 27 (2012), 181–188.
    • (2012) Cardiovasc Interv Ther , vol.27 , pp. 181-188
    • Kimura, T.1    Morimoto, T.2    Nakagawa, Y.3
  • 4
    • 84860135329 scopus 로고    scopus 로고
    • Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial
    • Valgimigli, M., Campo, G., Monti, M., et al., Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) Investigators. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 125 (2012), 2015–2026.
    • (2012) Circulation , vol.125 , pp. 2015-2026
    • Valgimigli, M.1    Campo, G.2    Monti, M.3
  • 5
    • 84926332974 scopus 로고    scopus 로고
    • ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
    • Schulz-Schüpke, S., Byrne, R.A., Ten Berg, J.M., et al., Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) Trial Investigators. ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. Eur Heart J 36 (2015), 1252–1263.
    • (2015) Eur Heart J , vol.36 , pp. 1252-1263
    • Schulz-Schüpke, S.1    Byrne, R.A.2    Ten Berg, J.M.3
  • 6
    • 84923348829 scopus 로고    scopus 로고
    • Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin: ITALIC, a randomized multicenter trial
    • Gilard, M., Barragan, P., Noryani, A.A., et al. Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin: ITALIC, a randomized multicenter trial. J Am Coll Cardiol 65 (2015), 777–786.
    • (2015) J Am Coll Cardiol , vol.65 , pp. 777-786
    • Gilard, M.1    Barragan, P.2    Noryani, A.A.3
  • 7
    • 84918810121 scopus 로고    scopus 로고
    • Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial
    • Colombo, A., Chieffo, A., Frasheri, A., et al. Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. J Am Coll Cardiol 64 (2014), 2086–2097.
    • (2014) J Am Coll Cardiol , vol.64 , pp. 2086-2097
    • Colombo, A.1    Chieffo, A.2    Frasheri, A.3
  • 8
    • 84856452781 scopus 로고    scopus 로고
    • Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study
    • Gwon, H.C., Hahn, J.Y., Park, K.W., et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation 125 (2012), 505–513.
    • (2012) Circulation , vol.125 , pp. 505-513
    • Gwon, H.C.1    Hahn, J.Y.2    Park, K.W.3
  • 9
    • 84918772240 scopus 로고    scopus 로고
    • Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
    • Mauri, L., Kereiakes, D.J., Yeh, R.W., et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 371 (2014), 2155–2166.
    • (2014) N Engl J Med , vol.371 , pp. 2155-2166
    • Mauri, L.1    Kereiakes, D.J.2    Yeh, R.W.3
  • 10
    • 84861371093 scopus 로고    scopus 로고
    • Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials
    • Stefanini, G.G., Byrne, R.A., Serruys, P.W., et al. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. Eur Heart J 33 (2012), 1214–1222.
    • (2012) Eur Heart J , vol.33 , pp. 1214-1222
    • Stefanini, G.G.1    Byrne, R.A.2    Serruys, P.W.3
  • 11
    • 84893663171 scopus 로고    scopus 로고
    • Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials
    • Sabaté, M., Räber, L., Heg, D., et al. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. J Am Coll Cardiol Intv 7 (2014), 55–63.
    • (2014) J Am Coll Cardiol Intv , vol.7 , pp. 55-63
    • Sabaté, M.1    Räber, L.2    Heg, D.3
  • 12
    • 0018687930 scopus 로고
    • A multiple testing procedure for clinical trials
    • O'Brien, P.C., Fleming, T.R., A multiple testing procedure for clinical trials. Biometrics 35 (1979), 549–556.
    • (1979) Biometrics , vol.35 , pp. 549-556
    • O'Brien, P.C.1    Fleming, T.R.2
  • 13
    • 0037453968 scopus 로고    scopus 로고
    • Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial
    • Lincoff, A.M., Bittl, J.A., Harrington, R.A., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289 (2003), 853–863.
    • (2003) JAMA , vol.289 , pp. 853-863
    • Lincoff, A.M.1    Bittl, J.A.2    Harrington, R.A.3
  • 14
    • 79959550517 scopus 로고    scopus 로고
    • Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
    • Mehran, R., Rao, S.V., Bhatt, D.L., et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123 (2011), 2736–2747.
    • (2011) Circulation , vol.123 , pp. 2736-2747
    • Mehran, R.1    Rao, S.V.2    Bhatt, D.L.3
  • 15
    • 34247558672 scopus 로고    scopus 로고
    • Clinical end points in coronary stent trials: a case for standardized definitions
    • Cutlip, D.E., Windecker, S., Mehran, R., et al., Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007), 2344–2351.
    • (2007) Circulation , vol.115 , pp. 2344-2351
    • Cutlip, D.E.1    Windecker, S.2    Mehran, R.3
  • 16
    • 84945957847 scopus 로고    scopus 로고
    • Final 3-year outcome of a randomized trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial
    • Natsuaki, M., Kozuma, K., Morimoto, T., et al. Final 3-year outcome of a randomized trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial. Circ Cardiovasc Interv, 8, 2015, e002817.
    • (2015) Circ Cardiovasc Interv , vol.8 , pp. e002817
    • Natsuaki, M.1    Kozuma, K.2    Morimoto, T.3
  • 17
    • 84959529733 scopus 로고    scopus 로고
    • Six versus 12 months of dual antiplatelet therapy after implantation of biodegradable polymer sirolimus-eluting stent: randomized substudy of the I-LOVE-IT 2 trial
    • Han, Y., Xu, B., Xu, K., et al. Six versus 12 months of dual antiplatelet therapy after implantation of biodegradable polymer sirolimus-eluting stent: randomized substudy of the I-LOVE-IT 2 trial. Circ Cardiovasc Interv, 9, 2016, e003145.
    • (2016) Circ Cardiovasc Interv , vol.9 , pp. e003145
    • Han, Y.1    Xu, B.2    Xu, K.3
  • 18
    • 85011390813 scopus 로고    scopus 로고
    • Initial experience of bioabsorbable polymer everolimus-eluting synergy stents in high-risk patients undergoing complex percutaneous coronary intervention with early discontinuation of dual-antiplatelet therapy
    • Noad, R.L., Hanratty, C.G., Walsh, S.J., Initial experience of bioabsorbable polymer everolimus-eluting synergy stents in high-risk patients undergoing complex percutaneous coronary intervention with early discontinuation of dual-antiplatelet therapy. J Invasive Cardiol 29 (2017), 36–41.
    • (2017) J Invasive Cardiol , vol.29 , pp. 36-41
    • Noad, R.L.1    Hanratty, C.G.2    Walsh, S.J.3
  • 19
    • 84993661556 scopus 로고    scopus 로고
    • Efficacy and safety of dual antiplatelet therapy after Complex PCI
    • Giustino, G., Chieffo, A., Palmerini, T., et al. Efficacy and safety of dual antiplatelet therapy after Complex PCI. J Am Coll Cardiol 68 (2016), 1851–1864.
    • (2016) J Am Coll Cardiol , vol.68 , pp. 1851-1864
    • Giustino, G.1    Chieffo, A.2    Palmerini, T.3
  • 20
    • 84938234622 scopus 로고    scopus 로고
    • Longer- versus shorter-duration dual-antiplatelet therapy after drug-eluting stent placement: a systematic review and meta-analysis
    • Spencer, F.A., Prasad, M., Vandvik, P.O., Chetan, D., Zhou, Q., Guyatt, G., Longer- versus shorter-duration dual-antiplatelet therapy after drug-eluting stent placement: a systematic review and meta-analysis. Ann Intern Med 163 (2015), 118–126.
    • (2015) Ann Intern Med , vol.163 , pp. 118-126
    • Spencer, F.A.1    Prasad, M.2    Vandvik, P.O.3    Chetan, D.4    Zhou, Q.5    Guyatt, G.6
  • 21
    • 77953668423 scopus 로고    scopus 로고
    • Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years
    • Ko, D.T., Yun, L., Wijeysundera, H.C., et al. Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years. Circ Cardiovasc Interv 3 (2010), 140–147.
    • (2010) Circ Cardiovasc Interv , vol.3 , pp. 140-147
    • Ko, D.T.1    Yun, L.2    Wijeysundera, H.C.3
  • 22
    • 84942826111 scopus 로고    scopus 로고
    • Balancing long-term risks of ischemic and bleeding complications after percutaneous coronary intervention with drug-eluting stents
    • Matteau, A., Yeh, R.W., Camenzind, E., et al. Balancing long-term risks of ischemic and bleeding complications after percutaneous coronary intervention with drug-eluting stents. Am J Cardiol 116 (2015), 686–693.
    • (2015) Am J Cardiol , vol.116 , pp. 686-693
    • Matteau, A.1    Yeh, R.W.2    Camenzind, E.3
  • 23
    • 84940050465 scopus 로고    scopus 로고
    • Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention
    • Généreux, P., Giustino, G., Witzenbichler, B., et al. Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention. J Am Coll Cardiol 66 (2015), 1036–1045.
    • (2015) J Am Coll Cardiol , vol.66 , pp. 1036-1045
    • Généreux, P.1    Giustino, G.2    Witzenbichler, B.3
  • 24
    • 0037182764 scopus 로고    scopus 로고
    • Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use
    • Lai, K.C., Lam, S.K., Chu, K.M., et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 346 (2002), 2033–2038.
    • (2002) N Engl J Med , vol.346 , pp. 2033-2038
    • Lai, K.C.1    Lam, S.K.2    Chu, K.M.3
  • 25
    • 78149487926 scopus 로고    scopus 로고
    • Clopidogrel with or without omeprazole in coronary artery disease
    • Bhatt, D.L., Cryer, B.L., Contant, C.F., et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 363 (2010), 1909–1917.
    • (2010) N Engl J Med , vol.363 , pp. 1909-1917
    • Bhatt, D.L.1    Cryer, B.L.2    Contant, C.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.